Environmental enrichment during development decreases intravenous self-administration of methylphenidate at low unit doses in rats

Behavioural Pharmacology

Volumn 23, Issue 7, 2012, Pages 650-657

  Alvers, Kristin M ^a   Marusich, Julie A ^a,b   Gipson, Cassandra D ^a,c   Beckmann, Joshua S ^a   Bardo, Michael T ^a  

^a UNIVERSITY OF KENTUCKY   (United States)

^b RTI INTERNATIONAL   (United States)

^c MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

environmental enrichment; methylphenidate; progressive ratio; rat; self administration

Indexed keywords

METHYLPHENIDATE;

ANIMAL EXPERIMENT; ARTICLE; DRUG DOSE COMPARISON; DRUG MEGADOSE; DRUG SELF ADMINISTRATION; ENVIRONMENTAL ENRICHMENT; LOW DRUG DOSE; MALE; NONHUMAN; RAT; REINFORCEMENT; SCANNING ELECTRON MICROSCOPY;

ANIMALS; CONDITIONING, OPERANT; DOPAMINE UPTAKE INHIBITORS; DOSE-RESPONSE RELATIONSHIP, DRUG; INFUSIONS, INTRAVENOUS; MALE; METHYLPHENIDATE; RATS; RATS, SPRAGUE-DAWLEY; REINFORCEMENT SCHEDULE; SELF ADMINISTRATION; SOCIAL ENVIRONMENT; SOCIAL ISOLATION;

EID: 84866326755     PISSN: 09558810     EISSN: 14735849     Source Type: Journal    
DOI: 10.1097/FBP.0b013e3283584765     Document Type: Article

References (67)

1. Bardo MT, Klebaur JE, Valone JM, Deaton C (2001). Environmental enrichment decreases intravenous self-administration of amphetamine in female and male rats. Psychopharmacology (Berl) 155:278-284. (Pubitemid 32477284)
2. Beckmann JS, Bardo MT (2012). Environmental enrichment reduces attribution of incentive salience to a food-associated stimulus. Behav Brain Res 226: 331-334.
3. Bergman J, Madras BK, Johnson SE, Spealman RD (1989). Effects of cocaine and related drugs in nonhuman primates. III. Self-administration by squirrel monkeys. J Pharmacol Exp Ther 251:150-155. (Pubitemid 19261957)
4. Biederman J, Wilens T, Mick E, Spencer T, Faraone SV (1999). Pharmacotherapy of attention-deficit/hyperactivity disorder reduces risk for substance use disorder. Pediatrics 104:e20.
5. Botly LCP, Burton CL, Rizos Z, Fletcher PJ (2008). Characterization of methylphenidate self-administration and reinstatement in the rat. Psycho-pharmacology (Berl) 199:55-66.
6. Boyle AE, Gill K, Smith BR, Amit Z (1991). Differential effects of an early housing manipulation on cocaine-induced activity and self-administration in laboratory rats. Pharmacol Biochem Behav 39:269-274.
7. Brown RT, Amler RW, Freeman WS, Perrin JM, Stein MT, Feldman HM, et al. (2005). Treatment of attention-deficit/hyperactivity disorder: overview of the evidence. Pediatrics 115:749-757.
8. Cain ME, Green TA, Bardo MT (2006). Environmental enrichment decreases responding for visual novelty. Behav Processes 73:360-366. (Pubitemid 44604434)
9. Carroll ME, Lac ST (1993). Autoshaping i.v. cocaine self-administration in rats: effects of nondrug alternative reinforcers on acquisition. Psychopharmacol-ogy 110:5-12. (Pubitemid 23029421)
10. Carroll ME, Anker JJ, Perry JL (2009). Modeling risk factors for nicotine and other drug abuse in the preclinical laboratory. Drug Alcohol Depend 104 (Suppl 1):S70-S78.
11. Chauvet C, Lardeux V, Goldberg SR, Jaber M, Solinas M (2009). Environmental enrichment reduces cocaine seeking and reinstatement induced by cues and stress but not by cocaine. Neuropsychopharmacol 34:2767-2778.
12. Dela Peña IC, Ahn HS, Choi JY, Shin CY, Ryu JH, Cheong JH (2011). Methylphenidate self-administration and conditioned place preference in an animal model of attention-deficit hyperactivity disorder: the spontaneously hypertensive rat. Behav Pharmacol 22:31-39.
13. Diamond MC (2001). Response of the brain to enrichment. An Acad Bras Cienc 73:211-220.
14. Gipson CD, Beckmann JS, El-Maraghi S, Marusich JA, Bardo MT (2011). Effect of environmental enrichment on escalation of cocaine self-administration in rats. Psychopharmacology (Berl) 214:557-566.
15. Gluck JP, Pearce HE (1977). Acquisition and extinction of an operant response in differentially reared rats. Dev Psychobiol 10:143-149. (Pubitemid 8101095)
16. Green TA, Gehrke BJ, Bardo MT (2002). Environmental enrichment decreases intravenous amphetamine self-administration in rats: dose-response functions for fixed-and progressive-ratio schedules. Psychopharmacology (Berl) 162:373-378. (Pubitemid 35001899)
17. Griffiths RR, Findley JD, Bray JV, Dolan-Gutcher K, Robinson WW (1975). Comparison of progressive-ratio performance maintained by cocaine, methylphenidate and secobarbital. Psychopharmacologia 43:81-83.
18. Han DD, Gu HH (2006). Comparison of the monoamine transporters from human and mouse in their sensitivities to psychostimulant drugs. BMC Pharmacol 6:6.
19. Herin DV, Rush CR, Grabowski J (2010). Agonist-like pharmacotherapy for stimulant dependence: preclinical, human laboratory and clinical studies. Ann N Y Acad Sci 1187:76-100.
20. Hoagwood K, Kelleher KJ, Feil M, Comer DM (2000). Treatment services for children with ADHD: a national perspective. J Am Acad Child Adolesc Psychiatry 39:198-206. (Pubitemid 30081963)
21. Howes SR, Dalley JW, Morrison CH, Robbins TW, Everitt BJ (2000). Leftward shift in the acquisition of cocaine self-administration in isolation-reared rats: relationship to extracellular levels of dopamine, serotonin and glutamate in the nucleus accumbens and amygdala-striatal FOS expression. Psychopharma-cology (Berl) 151:55-63. (Pubitemid 30639840)
22. Jardin B, Looby A, Earleywine M (2011). Characteristics of college students with attention-deficit hyperactivity disorder symptoms who misuse their medications. J Am Coll Health 59:373-377.
23. Johanson CE, Schuster CR (1975). A choice procedure for drug reinforcers: cocaine and methylphenidate in the rhesus monkey. J Pharmacol Exp Ther 193:676-688.
24. Kolb B, Gorny G, Soderpalm AH, Robinson TE (2003). Environmental complexity has different effects on the structure of neurons in the prefrontal cortex versus the parietal cortex or nucleus accumbens. Synapse 48:149-153. (Pubitemid 36444340)
25. Kollins SH, MacDonald EK, Rush CR (2001). Assessing the abuse potential of methylphenidate in nonhuman and human subjects: a review. Pharmacol Biochem Behav 68:611-627.
26. Koob GF, Kreek MJ (2007). Stress, dysregulation of drug reward pathways, and the transition to drug dependence. Am J Psychiatry 164:1149-1159. (Pubitemid 47292402)
27. Leonard BE, McCartan D, White J, King DJ (2004). Methylphenidate: a review of its neuropharmacological, neuropsychological and adverse clinical effects. Hum Psychopharmacol Clin Exp 19:151-180. (Pubitemid 38514828)
28. MacDonald EK, Kollins SH (2000). Assessing the reinforcing effects of methylphenidate in children diagnosed with ADHD using a choice procedure. Drug Alcohol Depend 60:S134.
29. Mannuzza S, Klein RG, Moulton JL III (2003). Does stimulant treatment place children at risk for adult substance abuse? A controlled, prospective follow-up study. J Child Adolesc Psychopharmacol 13:273-282. (Pubitemid 37288527)
30. Marusich JA, Beckmann JS, Gipson CD, Bardo MT (2010). Methylphenidate as a reinforcer for rats: contingent delivery and intake escalation. Exp Clin Psychopharmacol 18:257-266.
31. Marusich JA, Beckmann JS, Gipson CD, Bardo MT (2011a). Cue effects on methylphenidate self-administration in rats. Behav Pharmacol 22:714-717.
32. Marusich JA, Darna M, Charnigo RJ, Dwoskin LP, Bardo MT (2011b). A multivariate assessment of individual difference in sensation seeking and impulsivity as predictors of amphetamine self-administration and prefrontal dopamine function in rats. Exp Clin Psychopharmacol 19:275-284.
33. Marusich JA, McCuddy WT, Beckmann JS, Gipson CD, Bardo MT (2011c). Strain differences in self-administration of methylphenidate and sucrose pellets in a rat model of attention-deficit hyperactivity disorder. Behav Pharmacol 22:794-804.
34. McCabe SE, Teter CJ, Boyd CJ, Guthrie SK (2004). Prevalence and correlates of illicit methylphenidate use among 8th, 10th, and 12th grade students in the United States, 2001. J Adolesc Health 35:501-504. (Pubitemid 39576021)
35. Meisch RA (1987). Factor controlling drug reinforced behavior. Pharmacol Biochem Behav 27:367-371. (Pubitemid 17106873)
36. Musser CJ, Ahmann PA, Theve FW, Mundt P, Broste SK, Mueller-Rizner N (1998). Stimulant use and the potential for abuse in Wisconsin as reported by school administrators and longitudinally followed children. J Dev Behav Pediatr 19:187-192. (Pubitemid 128456246)
37. National Research Council (1996). Guide for the care and use of laboratory animals. Washington, DC: National Academy Press.
38. Ough BR, Beatty WW, Khalili J (1972). Effects of isolated and enriched rearing on response inhibition. Psychonomic Sci 27:293-294.
39. Perry JL, Carroll ME (2008). The role of impulsive behavior in drug abuse. Psychopharmacology (Berl) 200:1-26.
40. Perry JL, Stairs DJ, Bardo MT (2008). Impulsive choice and environmental enrichment: effects of D-amphetamine and methylphenidate. Behav Brain Res 193:48-54.
41. Ranaldi R, Kest K, Zellner M, Hachimine-Semprebrom P (2011). Environmental enrichment, administered after establishment of cocaine self-administration, reduces lever pressing in extinction and during a cocaine context renewal test. Behav Pharmacol 22:347-353.
42. Richardson NR, Roberts DCS (1996). Progressive ratio schedules in drug self-administration studies in rats: a method to evaluate reinforcing efficacy. J Neurosci Methods 66:1-11. (Pubitemid 26180064)
43. Risner ME, Jones BE (1976). Characteristics of unlimited access to self-administered stimulant infusions in dogs. Biol Psychiatry 11:625-634.
44. Robinson TE, Berridge KC (2008). The incentive sensitization theory of addiction: some current issues. Philos Trans R Soc Lond B Biol Sci 363: 3137-3146.
45. Rosenzweig MR, Bennett EL (1996). Psychobiology of plasticity: effects of training and experience on brain and behavior. Behav Brain Res 78:57-65. (Pubitemid 26179783)
46. Rush CR, Baker RW (2001). Behavioral pharmacological similarities between methylphenidate and cocaine in cocaine abusers. Exp Clin Psychopharmacol 9:59-73. (Pubitemid 32852215)
47. Rush CR, Kollins SH, Pazzaglia PJ (1998). Discriminative-stimulus and participant-rated effects of methylphenidate, bupropion and triazolam in D-amphetamine-trained humans. Exp Clin Psychopharmacol 6:32-44. (Pubitemid 28102884)
48. Rush CR, Essman WD, Simpson CA, Baker RW (2001). Reinforcing and subject-rated effects of methylphenidate and D-amphetamine under a modified progressive-ratio schedule. J Clin Psychopharmacol 21:273-286. (Pubitemid 32452932)
49. Setlik J, Bond GR, Ho M (2009). Adolescent prescription ADHD medication abuse is rising along with prescription for these medications. Pediatrics 124:875-880.
50. Sevak RJ, Stoops WW, Hays LR, Rush CR (2009). Discriminative-stimulus and subject-rated effects of methamphetamine, d-Amphetamine, methylphenidate and triazolam in methamphetamine-trained humans. J Pharmacol Exp Ther 328:1007-1018.
51. Simpson J, Kelly JP (2011). The impact of environmental enrichment in laboratory rats-behavioural and neurochemical aspects. Behav Brain Res 222: 246-264.
52. Smith JK, Neill JC, Costall B (1997). Post-weaning housing conditions influence the behavioural effects of cocaine and D-amphetamine. Psychopharmacology (Berl) 131:23-33. (Pubitemid 27242851)
53. Smith MA, Iordanou JC, Cohen MB, Cole KT, Gergans SR, Lyle MA, Schmidt KT (2009). Effects of environmental enrichment on sensitivity to cocaine in female rats: importance of control rates of behavior. Behav Pharmacol 20:312-321.
54. Sokolowski JD, Salamone JD (1994). Effects of dopamine depletions in the medial prefrontal cortex on DRL performance and motor activity in the rat. Brain Res 642:20-28. (Pubitemid 24105685)
55. Stafford D, LeSage MG, Glowa JR (1998). Progressive-ratio schedules of drug delivery in the analysis of drug self-administration: a review. Psychopharma-cology (Berl) 139:169-184. (Pubitemid 28439514)
56. Stairs DJ, Bardo MT (2009). Neurobehavioral effects of environmental enrichment and drug abuse vulnerability. Pharmacol Biochem Behav 92:377-382.
57. Stairs DJ, Klein ED, Bardo MT (2006). Effects of environmental enrichment on extinction and reinstatement of amphetamine self-administration and sucrose-maintained responding. Behav Pharmacol 17:597-604. (Pubitemid 44526736)
58. Stoops WW, Glaser PEA, Rush CR (2004). Reinforcing and subject-rated effects of methylphenidate and d-Amphetamine in stimulant abusing humans. J Psychopharmacol 18:534-543. (Pubitemid 39665121)
59. Teter CJ, McCabe SE, LaGrange K, Cranford JA, Boyd CJ (2006). Illicit use of specific prescription stimulants among college students: prevalence, motives, and routes of administration. Pharmacotherapy 26:1501-1510. (Pubitemid 44521735)
60. Thiel KJ, Engelhardt B, Hood LE, Peartree NA, Neisewander JL (2011). The interactive effects of environmental enrichment and extinction interventions in attenuating cue-elicited cocaine-seeking behavior in rats. Pharmacol Biochem Behav 97:595-602.
61. Tzschentke TM (2000). The medial prefrontal cortex as a part of the brain reward system. Amino Acids 19:211-219.
62. Wilens TE (2008). Effects of methylphenidate on the catecholaminergic system in attention-deficit/hyperactivity disorder. J Clin Psychopharmacol 28: S46-S53.
63. Wilens TE, Faraone SV, Biederman J, Gunawardene S (2003). Does stimulant therapy of attention-deficit/hyperactivity disorder beget later substance abuse? A meta-analytic review of the literature. Pediatrics 111:179-185. (Pubitemid 36071051)
64. Wood DE, Siegel AK, Rebec GV (2006). Environmental enrichment reduces impulsivity during appetitive conditioning. Physiol Behav 88:132-137. (Pubitemid 43795964)
65. Wooters TE, Bardo MT, Dwoskin LP, Midde NM, Gomez AM, Mactutus CF, et al. (2011). Effect of environmental enrichment on methylphenidate-induced locomotion and dopamine transporter dynamics. Behav Brain Res 16: 98-107.
66. Zhu J, Green T, Bardo MT, Dwoskin LP (2004). Environmental enrichment enhances sensitization to GBR 12935-induced activity and decreases dopamine transporter function in the medial prefrontal cortex. Behav Brain Res 148:107-117. (Pubitemid 37543660)
67. Zhu J, Apparsundaram S, Bardo MT, Dwoskin LP (2005). Environmental enrichment decreases cell surface expression of the dopamine transporter in rat medial prefrontal cortex. J Neurochem 93:1434-1443. (Pubitemid 40853266)